EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Organoids: Breakthroughs in Clinical Decision Making, Drug Development, and Translational Advances Beyond Conventional Models

Yimao Wu, Ruowei Sun, Gokhan Zengin, Shuai Ren, Meng‐Yao Li

Med Research · 2026-03 · 2 (1) · 26-40

DOI: 10.1002/mdr2.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Med Research, online erschienen am 14.12.2025. Verfasst von Yimao Wu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor organoid models are revolutionizing cancer research by bridging the translational gap between conventional two‐dimensional cell cultures and animal models. This Editorial thoroughly explores the fundamental innovations of patient‐derived organoid technology. Firstly, it achieves highly physiologically relevant disease modeling by preserving the genetic heterogeneity and microenvironmental complexity of patient tumors. Secondly, it uniquely integrates microfluidic chips, artificial intelligence, and single‐cell multi‐omics analysis to facilitate high‐throughput drug screening and accurate efficacy prediction. Thirdly, it has significantly advanced the development of immune co‐culture models and the study of tumor–immune interactions, offering a novel platform for examining immune therapy resistance mechanisms. The paper also critically assesses the current challenges in clinical translation, such as the lack of standardization and the complexity of vascular network reconstruction, and suggests future directions focusing on “organoid biobanks” and multicenter clinical validation. This Editorial not only systematically discusses the technological evolution but also provides a theoretical framework and practical path for transitioning organoids from basic research to clinical decision‐making, thereby ushering in a new era of precision cancer medicine.

Zitieren

APA

Wu, Y., Sun, R., Zengin, G., Ren, S., & Li, M. (2026). Tumor Organoids: Breakthroughs in Clinical Decision Making, Drug Development, and Translational Advances Beyond Conventional Models. Med Research, 2(1), 26-40. https://doi.org/10.1002/mdr2.70048

Vancouver

Wu Y, Sun R, Zengin G, Ren S, Li M. Tumor Organoids: Breakthroughs in Clinical Decision Making, Drug Development, and Translational Advances Beyond Conventional Models. Med Research. 2026;2(1):26-40. doi:10.1002/mdr2.70048

BibTeX
@article{Wu2026,
  author = {Wu, Yimao and Sun, Ruowei and Zengin, Gokhan and Ren, Shuai and Li, Meng‐Yao},
  title = {Tumor Organoids: Breakthroughs in Clinical Decision Making, Drug Development, and Translational Advances Beyond Conventional Models},
  journal = {Med Research},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {26--40},
  doi = {10.1002/mdr2.70048}
}
Kostenlos starten →